Male reproductive hormones in patients treated with pretomanid

BACKGROUND: Pretomanid (Pa) is a nitroimidazole-class drug recently approved by the US Food and Drug Administration and other regulatory authorities as part of a regimen for treating highly drug-resistant pulmonary Mycobacterium tuberculosis infections. Studies in rodents identified the testis as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Boekelheide, K., Olugbosi, M., Nedelman, J., Everitt, D., Smith, E., Betteridge, M., Sun, E., Spigelman, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union Against Tuberculosis and Lung Disease 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165738/
https://www.ncbi.nlm.nih.gov/pubmed/35650700
http://dx.doi.org/10.5588/ijtld.21.0654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165738/
https://www.ncbi.nlm.nih.gov/pubmed/35650700
http://dx.doi.org/10.5588/ijtld.21.0654

Ejemplares similares